Research Tracker›Biomarker Atlas›PACVS›Exertional SpO₂ nadir

Exertional SpO₂ nadir in PACVS

Exertional SpO₂ nadir, also described as Pulse oximetry, belongs to the functional group of PACVS (PACVS, PCVS) markers and is reported to be decreased relative to healthy controls. Clinically, it has been associated with exercise-induced hypoxemia. The finding is drawn from Halma 2024; it describes group-level differences, not a threshold that classifies an individual.

↓ ReducedFunctional

Summary

Direction in PACVS↓ Reduced — lower than in the comparison group
CategoryFunctional
Also described asPulse oximetry
Compared againstHC (healthy controls)
Associated symptomsExercise-induced hypoxemia
Test typeClinical or physiological test
SourceHalma 2024 — doi:10.2196/preprints.70342
Condition atlasPACVS Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Change in Pulse Oximetry at Rest and During the 6MWT (7 registered trials use a matching outcome measure).

Clinical trials using Exertional SpO₂ nadir as an outcome

NCT05877534Active Not Recruiting
Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study
Outcome measure: Change in oxygen saturation during 6 minute walk test
NCT06231238Active Not Recruiting
Balance Acceptance and Commitment Therapy for Long COVID
Outcome measure: Lung function (spirometry, Resting pulse oximetry; SpO2)
NCT07492953Completed
Using Enhanced External Counterpulsation to Recover Cardiovascular Function for Patient of Chronic Diseases
Outcome measure: Peak oxygen uptake (Peak VO₂)
NCT05094622Active Not Recruiting
Physical Training in Patients With POTS After Covid-19
Outcome measure: Change in oxygen saturation during 6 minute walk test
BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients
Outcome measure: Change in Pulse Oximetry at Rest and During the 6MWT
NCT04905888Withdrawn
Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela
Outcome measure: Exercise tolerance
NCT07579026Recruiting
Effects of Breathing Retraining Exercises in Pregnant Females With Postural Orthostatic Tachycardia Syndrome.
Outcome measure: Pulse oximetry

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Related Functional markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is Exertional SpO₂ nadir high or low in PACVS?

Reduced. Studies summarised in the OSMF atlas report lower Exertional SpO₂ nadir in PACVS than in healthy controls. Source: Halma 2024.

What symptoms is Exertional SpO₂ nadir associated with in PACVS?

The cited literature associates this marker with Exercise-induced hypoxemia. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Exertional SpO₂ nadir?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Exertional SpO₂ nadir result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. Exertional SpO₂ nadir findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Exertional SpO₂ nadir in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/exertional-spo2-nadir.html

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.